CA1085848A - Aspidospermidines - Google Patents
AspidospermidinesInfo
- Publication number
- CA1085848A CA1085848A CA281,276A CA281276A CA1085848A CA 1085848 A CA1085848 A CA 1085848A CA 281276 A CA281276 A CA 281276A CA 1085848 A CA1085848 A CA 1085848A
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- alkali metal
- formula
- carbanion
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YAAIPCQYJYPITK-UHFFFAOYSA-N (+)-Aspidospermidine Natural products C1=CC=C2C3(C45)CCN5CCCC4(CC)CCC3NC2=C1 YAAIPCQYJYPITK-UHFFFAOYSA-N 0.000 claims abstract 2
- YAAIPCQYJYPITK-NCXUSEDFSA-N aspidospermidine Chemical compound C1=CC=C2[C@]3([C@@H]45)CCN5CCC[C@]4(CC)CC[C@H]3NC2=C1 YAAIPCQYJYPITK-NCXUSEDFSA-N 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 14
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 229910052783 alkali metal Inorganic materials 0.000 claims description 8
- 150000001340 alkali metals Chemical class 0.000 claims description 8
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 7
- 239000001301 oxygen Substances 0.000 claims description 7
- 229910052760 oxygen Inorganic materials 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- -1 alkali metal amide Chemical class 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 229910001413 alkali metal ion Inorganic materials 0.000 claims description 2
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims 1
- 150000008046 alkali metal hydrides Chemical class 0.000 claims 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 150000001342 alkaline earth metals Chemical class 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 150000002432 hydroperoxides Chemical class 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
- GIGFIWJRTMBSRP-UHFFFAOYSA-N DL-Vincadifformin Natural products C1C(C(=O)OC)=C2NC3=CC=CC=C3C22CCN3CCCC1(CC)C23 GIGFIWJRTMBSRP-UHFFFAOYSA-N 0.000 abstract description 2
- 229940124549 vasodilator Drugs 0.000 abstract 1
- 239000003071 vasodilator agent Substances 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229960002726 vincamine Drugs 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910019020 PtO2 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- YKIOKAURTKXMSB-UHFFFAOYSA-N adams's catalyst Chemical compound O=[Pt]=O YKIOKAURTKXMSB-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 229910052744 lithium Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- KUAZQDVKQLNFPE-UHFFFAOYSA-N thiram Chemical compound CN(C)C(=S)SSC(=S)N(C)C KUAZQDVKQLNFPE-UHFFFAOYSA-N 0.000 description 2
- 229960002447 thiram Drugs 0.000 description 2
- JSLDLCGKZDUQSH-RTBUJCADSA-N 19-epivindolinine Natural products O=C(OC)[C@H]1[C@@]23[C@H](C)[C@]4([C@@H]5N(CC=C4)CC[C@]25c2c(N3)cccc2)C1 JSLDLCGKZDUQSH-RTBUJCADSA-N 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KILNDJCLJBOWAN-UHFFFAOYSA-N Tabersonine Natural products CCC12CC(=C3N(C)c4cc(OC)ccc4C35CCN(CC=C1)C25)C(=O)OC KILNDJCLJBOWAN-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229910001919 chlorite Inorganic materials 0.000 description 1
- 229910052619 chlorite group Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical class Cl* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- SMBQBQBNOXIFSF-UHFFFAOYSA-N dilithium Chemical compound [Li][Li] SMBQBQBNOXIFSF-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- CRGZYKWWYNQGEC-UHFFFAOYSA-N magnesium;methanolate Chemical compound [Mg+2].[O-]C.[O-]C CRGZYKWWYNQGEC-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical class [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- CGRKYEALWSRNJS-UHFFFAOYSA-N sodium;2-methylbutan-2-olate Chemical compound [Na+].CCC(C)(C)[O-] CGRKYEALWSRNJS-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- FNGGIPWAZSFKCN-ACRUOGEOSA-N tabersonine Chemical compound N1C2=CC=CC=C2[C@]2([C@H]34)C1=C(C(=O)OC)C[C@]3(CC)C=CCN4CC2 FNGGIPWAZSFKCN-ACRUOGEOSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- FNGGIPWAZSFKCN-UHFFFAOYSA-N xi-tabersonine Natural products N1C2=CC=CC=C2C2(C34)C1=C(C(=O)OC)CC3(CC)C=CCN4CC2 FNGGIPWAZSFKCN-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7621431A FR2358147A1 (fr) | 1976-07-13 | 1976-07-13 | Aspidospermidines |
| FR7621431 | 1976-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1085848A true CA1085848A (fr) | 1980-09-16 |
Family
ID=9175673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA281,276A Expired CA1085848A (fr) | 1976-07-13 | 1977-06-23 | Aspidospermidines |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4152519A (enExample) |
| JP (1) | JPS539798A (enExample) |
| AT (1) | AT358189B (enExample) |
| AU (1) | AU512242B2 (enExample) |
| BE (1) | BE856722A (enExample) |
| BR (1) | BR7704588A (enExample) |
| CA (1) | CA1085848A (enExample) |
| CH (1) | CH622794A5 (enExample) |
| DE (1) | DE2731481A1 (enExample) |
| ES (1) | ES460400A1 (enExample) |
| FR (1) | FR2358147A1 (enExample) |
| GB (1) | GB1546308A (enExample) |
| IT (1) | IT1081020B (enExample) |
| LU (1) | LU77727A1 (enExample) |
| NL (1) | NL7707721A (enExample) |
| NZ (1) | NZ184636A (enExample) |
| ZA (1) | ZA774039B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2439200A2 (fr) * | 1978-10-19 | 1980-05-16 | Sandoz Sa | Nouveaux derives de la 1,2-didehydro-aspidospermidine, leur preparation et leur application comme medicaments |
| HU206883B (en) * | 1990-12-18 | 1993-01-28 | Richter Gedeon Vegyeszet | Process for producing new 15-nitro-2-beta-, 3-beta-dihydro- and 15-nitro-2-beta, 3-beta-, 6,7-tetrahydro-tabersonin derivatives and pharmaceutical compositions containing them |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE763730R (fr) * | 1971-01-15 | 1971-08-02 | Omnium Chimique Sa | Procede de preparation de la vincamine naturelle a partir de latabersonine et derives indoliques |
| BE765427A (fr) * | 1971-04-07 | 1971-08-30 | Omnium Chimique Sa | Procede de preparation de la vincine naturelle a partir de la (-) mehtoxy-11-tabersonine et derives indoliques nouveaux. |
| BE765795A (fr) * | 1971-04-15 | 1971-08-30 | Omnium Chimique Sa | Procede de preparation d'inverses optiques de la vincamine naturelle etderives indoliques nouveaux. |
| FR2242395B1 (enExample) * | 1973-06-22 | 1978-10-20 | Omnium Chimique Sa |
-
1976
- 1976-07-13 FR FR7621431A patent/FR2358147A1/fr active Granted
-
1977
- 1977-06-23 CA CA281,276A patent/CA1085848A/fr not_active Expired
- 1977-07-05 ZA ZA00774039A patent/ZA774039B/xx unknown
- 1977-07-05 ES ES460400A patent/ES460400A1/es not_active Expired
- 1977-07-07 US US05/813,670 patent/US4152519A/en not_active Expired - Lifetime
- 1977-07-11 LU LU77727A patent/LU77727A1/xx unknown
- 1977-07-12 BE BE179265A patent/BE856722A/xx not_active IP Right Cessation
- 1977-07-12 AT AT500077A patent/AT358189B/de not_active IP Right Cessation
- 1977-07-12 AU AU26947/77A patent/AU512242B2/en not_active Expired
- 1977-07-12 DE DE19772731481 patent/DE2731481A1/de not_active Ceased
- 1977-07-12 NL NL7707721A patent/NL7707721A/xx not_active Application Discontinuation
- 1977-07-12 IT IT12681/77A patent/IT1081020B/it active
- 1977-07-12 GB GB29234/77A patent/GB1546308A/en not_active Expired
- 1977-07-12 CH CH862677A patent/CH622794A5/fr not_active IP Right Cessation
- 1977-07-13 BR BR7704588A patent/BR7704588A/pt unknown
- 1977-07-13 JP JP8399277A patent/JPS539798A/ja active Pending
- 1977-07-13 NZ NZ184636A patent/NZ184636A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA774039B (en) | 1978-05-30 |
| AT358189B (de) | 1980-08-25 |
| FR2358147B1 (enExample) | 1978-12-15 |
| GB1546308A (en) | 1979-05-23 |
| IT1081020B (it) | 1985-05-16 |
| AU512242B2 (en) | 1980-10-02 |
| CH622794A5 (enExample) | 1981-04-30 |
| BE856722A (fr) | 1978-01-12 |
| BR7704588A (pt) | 1978-04-04 |
| US4152519A (en) | 1979-05-01 |
| NL7707721A (nl) | 1978-01-17 |
| ATA500077A (de) | 1980-01-15 |
| JPS539798A (en) | 1978-01-28 |
| DE2731481A1 (de) | 1978-01-19 |
| AU2694777A (en) | 1979-01-18 |
| NZ184636A (en) | 1980-04-28 |
| LU77727A1 (enExample) | 1977-10-07 |
| ES460400A1 (es) | 1978-05-01 |
| FR2358147A1 (fr) | 1978-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4474802A (en) | 5,6,7-Trinor-4,8-inter-m-phenylene prostaglandin I2 derivatives useful in anti-ulcer, hypotensive and platelet aggregation inhibiting compositions | |
| EP1626045A1 (en) | Processes for producing 3-substituted 2-chloro-5-fluoropyridine or salt thereof | |
| CA1084931A (fr) | Procede de preparation de la vincamine et d'alcaloides apparentes | |
| US4806280A (en) | Process for the preparation of unsaturated compound α-chlorinated with respect to two electron-attracting groups in a β-position | |
| Stevens et al. | gem-Dihalides from the Hofmann Degradation of α-Haloamides1 | |
| US3646222A (en) | Method for production of substituted hydroquinones | |
| CN119431211B (zh) | 一种中间体及其制备方法和应用 | |
| US5169959A (en) | Free radical-catalyzed synthesis of benzoprostacyclins | |
| Stanforth | The Wittig reaction of fluorinated amides: formation of enamine and imine tautomers | |
| FR2602766A1 (fr) | Composes dichlorotrifluoromethylnitrotoluenes et procede de preparation d'aminotrifluoromethyltoluenes a partir de ces composes | |
| Bennetau et al. | Synthesis of 3-Benzoylcyclohexanone, A key Intermediate for the Synthesis of Ketoprofen | |
| JP3382681B2 (ja) | 含フッ素化合物およびその製法 | |
| EP0065909B1 (fr) | ((Pipéridyl-4)-2 alkyl-1 éthyl)-3 indoles et leur utilisation comme médicaments | |
| US5808132A (en) | α,α-bis(trifluoromethyl)arylacetic acid ester; its intermediates for synthesis; and process for producing the same | |
| US4028420A (en) | Process for the preparation of hex-2-enal | |
| AU623306B2 (en) | Process for producing isoxazole derivative | |
| JP2870707B2 (ja) | ３−ブテンニトリル類の製造方法 | |
| KR100278967B1 (ko) | 오르쏘-디플루오로벤조산 유도체의 제조방법 | |
| FR2487825A1 (fr) | Procede de preparation d'esters d'acides acylazo-3 propioniques | |
| JP3313820B2 (ja) | 環式カルボン酸およびエステルの製法 | |
| JP3008296B2 (ja) | ジアリールグリコール酸の製造方法 | |
| WO2022218348A1 (en) | Method for synthesizing lactam compounds | |
| KR20190022894A (ko) | 3-(트리플루오로메틸)피라진-2-카르복실산 에스테르의 제조 방법 | |
| CH622794A5 (enExample) | ||
| JPS5867634A (ja) | 置換ジエンアルコ−ルおよびその製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |